Asker’s climate targets approved by SBTi

Asker Healthcare Group’s emissions reduction targets has been validated as science-based by the Science Based Target initiative (SBTi).

 “The climate crisis has serious consequences for our planet. Taking action is essential to ensure a sustainable future for generations to come. As a leading distributor of medical supplies, devices and equipment in Europe and a vital link between product companies and patients, we aim to use our position to contribute to lowering greenhouse gas (GHG) emissions from the healthcare sector”, says Johan Falk, CEO at Asker Healthcare Group.

To ensure Asker’s climate goals are aligned with the latest advances in climate science, the emissions reduction targets have undergone assessment by the Science Based Targets initiative (SBTi). The SBTi has now validated the targets as science-based and consistent with reductions required to keep global warming to 1.5°C, in line with the Paris Agreement.

The SBTi has validated the following targets:

  • Asker commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year.
  • Asker also commits to reduce scope 3 GHG emissions from purchased goods and services 51.6% per million SEK value added (purchased products and services in relation to gross income) within the same timeframe.

“Having our targets validated by the SBTi further strengthens our commitment in reducing GHG emissions. We are focused on increasing the use of renewable energy and improving energy efficiency in our facilities as well as increasing the share of products with lower GHG emissions. Simultaneously, we are working together with suppliers so they reduce emissions in their manufacturing process”, says Sanna Norman, Head of ESG at Asker Healthcare Group.

For further information, please contact:

Emma Rheborg, Head of Communication Asker Healthcare Group

Phone: +46 73 313 62 17

E-mail: emma.rheborg@asker.com


Asker Healthcare Group is a partner to caregivers across Europe, providing medical supplies, devices and equipment. We build and acquire leading companies that support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. The group has 2,400 employees in 14 countries and revenues amounts to SEK 12 billion.